Having gained CE mark approval for its offering back in March 2014, French orthopaedic imaging specialist EOS imaging, tells us that the U.S. FDA has now approved hipEOS, 3D hip arthroplasty planning software based on EOS stereo-radiographic 2D/3D imaging.
EOS says its hipEOS system is the first offering of a procedure-specific software portfolio associated with the EOS imaging system. Developed by OneFit medical, an EOS imaging group company, the software enables surgeons to perform pre-surgical planning including hip implant selection and virtual positioning in functional, weight-bearing 3D.
The software takes full advantage of what EOS imaging refers to as bias-free, real size 3D patient anatomical information obtained from the EOS exam to help physicians define implant size and visualize pre-operatively the restoration expected from a total hip arthroplasty prior to surgery.
Hip arthroplasty is the first procedure that will be addressed with planning software utilizing the advantages of EOS unique imaging. The Company intends to expand the suite of offerings to include additional orthopedic surgery planning software.
Marie Meynadier, CEO of EOS imaging, said, “hipEOS is the first step of our strategy to fully utilize EOS’ unique stereo-radiographic 2D/3D patient data in software tools that will help surgeons plan and execute precise surgical and non surgical treatments. We are very happy to have been granted market approval in the U.S. and to extend this offering, which has received a very positive feedback at the French SOFCOT launch in November, to our U.S. users and future users.”